| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.607 | 40.802 | 46.294 | 35.203 | 27.444 | 20.923 | 18.657 | 27.045 | 32.020 | 34.439 |
| Total Income - EUR | 31.608 | 40.802 | 46.294 | 35.239 | 27.444 | 20.923 | 18.657 | 28.669 | 32.020 | 34.569 |
| Total Expenses - EUR | 31.241 | 37.400 | 42.825 | 33.907 | 27.386 | 19.002 | 18.076 | 25.138 | 27.723 | 28.890 |
| Gross Profit/Loss - EUR | 367 | 3.402 | 3.468 | 1.332 | 58 | 1.921 | 581 | 3.531 | 4.297 | 5.678 |
| Net Profit/Loss - EUR | -581 | 2.585 | 3.005 | 979 | -216 | 1.340 | 21 | 2.671 | 3.532 | 4.563 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Novaintermedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9.038 | 12.993 | 16.716 | 11.551 | 8.716 | 8.270 | 7.890 | 11.542 | 13.114 | 17.284 |
| Inventories | 2.265 | 2.014 | 1.887 | 2.420 | 1.830 | 1.431 | 2.201 | 1.725 | 2.052 | 2.180 |
| Receivables | 6.606 | 10.272 | 13.425 | 8.710 | 6.079 | 5.451 | 4.103 | 7.197 | 8.207 | 12.217 |
| Cash | 167 | 707 | 1.405 | 420 | 807 | 1.388 | 1.586 | 2.619 | 2.855 | 2.887 |
| Shareholders Funds | -17.137 | -14.377 | -11.128 | -9.945 | -9.968 | -8.440 | -8.231 | -5.586 | -2.036 | 2.537 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.225 | 27.442 | 27.936 | 21.598 | 18.762 | 16.787 | 16.235 | 17.231 | 15.277 | 14.747 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Novaintermedical Srl